|
|
Article: Geron Corporation Reports Issuance of Second U.S. Patent for Nuclear Transfer Technology.
- Article from:
- Business Wire
- Article date:
- June 26, 2001
CopyrightCOPYRIGHT 2001 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business Editors/Health & Medical Writers
MENLO PARK, Calif.--(BW HealthWire)--June 26, 2001
Geron Corporation (Nasdaq:GERN) announced today that the U.S. Patent Office has issued U.S. Patent No. 6,252,133, with claims directed to methods of cloning non-human mammals using nuclear transfer.
"This patent covers nuclear transfer technology that utilizes nuclear donor cells that are actively proliferating in the G1 stage of the cell cycle, as well as nuclear donor cells that are quiescent," noted David J. Earp, J.D., Ph.D., Geron's vice president of intellectual property. "The claims cover, but are not limited to, somatic cell nuclear transfer, ...